Several central issues 1 stand out, paraphrased from a report by the OWG Chair: The report was phrased to preserve the anonymity of its contributors. The OWG review of draft revisions to the CDC guideline was structured around a top-level listing of 12 recommendations made by the NCIPC writers group with observations and concerns voiced by members of the OWG. If the CDC continues along a pathway at odds with its overall mission, then a major change of direction is needed in the ongoing revision of the 2016 opioid prescribing guideline(iStock).
The meeting minutes have been released and are available, and a full revision to the controversial CDC guideline is expected in 2022. To hear public comment on the 2016 guideline and its interim revision.To review findings of the advisory CDC Opioid Workgroup (OWG) appointed by the BSC in January 2020 the OWG was tasked with overseeing and evaluating an interim draft of the revised CDC guideline generated by the NCIPC writers group.To review the process and progress in an ongoing revision of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.The agenda for this meeting was three-fold: On July 16, 2021, the Board of Scientific Counselors (BSC)of the CDC National Center for Injury Prevention and Control (NCIPC) held a public meeting by podcast.
